A detailed history of First Republic Investment Management, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 15,246 shares of MRNA stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,246
Holding current value
$1.77 Million
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$96.41 - $126.61 $1.47 Million - $1.93 Million
15,246 New
15,246 $1.57 Million
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $389,344 - $565,447
2,870 Added 6.6%
46,341 $7.12 Million
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $484,055 - $858,853
4,089 Added 10.38%
43,471 $7.81 Million
Q3 2022

Nov 03, 2022

BUY
$118.07 - $194.18 $2.2 Million - $3.62 Million
18,636 Added 89.83%
39,382 $4.66 Million
Q2 2022

Aug 16, 2022

SELL
$117.13 - $176.59 $4.57 Million - $6.89 Million
-39,006 Reduced 65.28%
20,746 $2.96 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $4.56 Million - $8.48 Million
-36,096 Reduced 37.66%
59,752 $10.3 Million
Q4 2021

Feb 09, 2022

SELL
$225.82 - $368.51 $681,750 - $1.11 Million
-3,019 Reduced 3.05%
95,848 $24.3 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $2.15 Million - $4.69 Million
9,679 Added 10.85%
98,867 $38.1 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $9.69 Million - $17.5 Million
74,558 Added 509.62%
89,188 $21 Million
Q1 2021

May 14, 2021

SELL
$109.18 - $185.98 $86,470 - $147,296
-792 Reduced 5.14%
14,630 $1.92 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $315,486 - $815,158
4,799 Added 45.18%
15,422 $1.61 Million
Q3 2020

Nov 12, 2020

SELL
$54.34 - $94.85 $18,149 - $31,679
-334 Reduced 3.05%
10,623 $752,000
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $10,414 - $28,080
351 Added 3.31%
10,957 $704,000
Q1 2020

May 13, 2020

BUY
$17.78 - $31.58 $188,574 - $334,937
10,606 New
10,606 $318,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.